查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1887178

DNA连接酶市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032）

DNA Ligases Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

DNA连接酶市场成长驱动因素

全球DNA连接酶市场持续快速成长，主要受基因工程、分子诊断和新一代定序工作流程中应用不断扩展的推动。根据最新的产业评估，该市场在2024年的价值为3.507亿美元，预计到2025年将达到3.782亿美元。预计到2032年将进一步成长至6.927亿美元，2025年至2032年的复合年增长率将达到7.6%。基因组学、个人化医疗和基因编辑技术的快速发展也为此成长提供了支持。

2024年，北美以51.58%的市占率引领全球市场，这得益于其强大的研究基础设施、技术领先地位以及日益活跃的合作与收购活动。美国仍然是核心贡献者，这得益于其先进的生物技术生态系统以及CRISPR-Cas9和相关基因编辑工具的高普及率，这些工具需要DNA连接酶来进行精确的DNA修復。

DNA连接酶在DNA复製、修復、重组和克隆中发挥核心作用。它们的应用范围涵盖次世代定序（NGS）文库建构、基因合成和分子诊断。如此广泛的应用正在推动全球需求的成长，尤其是在合成生物学、基因疗法和客製化疗法领域日益受到关注的推动。

市场成长驱动因素

基因编辑技术的广阔前景是推动市场成长最强劲的动力之一。对 CRISPR-Cas9 研究投入的不断增加，以及利用基因工程细胞进行的临床研究的增多，正在加速对高品质 DNA 连接酶的需求。值得注意的是，KSQ Therapeutics 公司于 2024 年获得了 FDA 对其 CRISPR-Cas9 工程化 TIL 候选药物的批准，这凸显了基因编辑工具在临床应用方面的扩展。

此外，遗传疾病的增加以及向个人化医疗的快速转变进一步强化了对基于酶的分子工具的需求。 DNA 连接酶在治疗药物开发过程中仍然至关重要，尤其是在基于重组 DNA 和克隆技术的研究方法中。

市场限制因素与挑战

儘管市场发展势头强劲，但仍面临着一些限制因素，例如基因编辑中的脱靶效应、酶递送系统的挑战以及熟练分子生物学家的短缺。围绕先进基因工程技术的复杂监管也延缓了产品的审批和商业化週期。专业连接酶的高昂成本对规模较小的研究机构，尤其是在新兴经济体，构成了额外的障碍。

机会概观

策略合作、技术创新和区域市场扩张是关键的成长机会。各公司正大力投资开发适用于先进基因组学应用的高效连接酶。例如，生物技术收购旨在扩大重组酶的生产能力，例如 Fortis Life Sciences 收购 Empirical Biosciences 以增强其分子试剂产品组合。

由于研究能力的提升和生物製药生产设施的扩张，亚太地区正成为成长最快的市场。中国对商业化 DNA 片段生产和基因组学平台的投资正在推动该地区对 DNA 连接酶的需求。

细分市场概览

截至2024年，T4 DNA连接酶占最大市场占有率，这主要得益于其多功能性以及在克隆和基因工程工作流程中的广泛应用。同时，T7 DNA连接酶市场预计将在2032年前快速成长，这主要得益于其在合成生物学和生物製药研究领域的应用。

依应用领域划分，基因组学和基因工程将在2024年引领市场，这主要得益于基于CRISPR的基因编辑技术和定制基因组修饰的日益普及。製药和生物技术公司占了终端用户需求的大部分，这主要得益于基因治疗、疫苗研发和重组DNA技术的扩展。

2032 年区域展望

  • 北美（2024 年市场规模：1.809 亿美元）－凭藉强大的研发实力、基因编辑工具的高普及率以及持续的产业整合，保持领先地位。
  • 欧洲－凭藉活跃的学术研究和支持基因组学的健全监管框架，保持第二大市场规模。
  • 亚太地区－预计到 2032 年将实现最高的复合年增长率，这主要得益于生物技术投资的不断增长。
  • 拉丁美洲、中东/非洲—预计基因组学的广泛应用和政府主导的措施将推动成长。

主要参与者

主要参与者包括 Thermo Fisher Scientific、New England Biolabs、Takara Bio、Agilent Technologies、Promega Corporation、Bio-Rad Laboratories 和 Fortis Life Sciences，它们专注于酵素创新和扩展基因组工具包。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • DNA修饰技术进展
  • 基因工程技术进展
  • 主要公司新产品发布
  • 主要产业趋势（併购、合作等）
  • 新冠疫情对市场的影响

第五章：全球DNA连接酶市场分析、洞察与预测 （2019-2032）

  • 市场分析、洞察与预测 - 依类型划分
    • T7 DNA
    • T4 DNA
    • 其他
  • 市场分析、洞察与预测 - 依应用划分
    • 基因体学与基因工程
    • 药物发现与研究
    • 其他
  • 市场分析、洞察与预测 - 依最终用户划分
    • 製药和生技公司
    • 学术和研究机构
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美DNA连接酶市场分析、洞察与预测，2019-2032

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲DNA连接酶市场分析、洞察与预测，2019-2032

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区DNA连接酶市场分析、洞察与预测，2019-2032

  • 依国家/地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲 DNA 连接酶市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章 中东与非洲 DNA 连接酶市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 其他中东和非洲国家

第十一章 竞争格局分析

  • 全球市占率分析（2024）
  • 公司简介
  • 赛默飞世尔科技公司
  • 新英格兰生物实验室
  • 丹纳赫公司
  • 福蒂斯生命科学股份有限公司
  • 普罗米加公司
  • 伯乐生物实验室
  • BioCat GmbH
  • 宝生物公司
  • 安捷伦科技公司
Product Code: FBI112712

Growth Factors of DNA ligases Market

The global DNA ligases market continues to advance rapidly due to rising applications in genetic engineering, molecular diagnostics, and next-generation sequencing workflows. According to the latest industry assessment, the market was valued at USD 350.7 million in 2024 and is projected to reach USD 378.2 million in 2025, eventually expanding to USD 692.7 million by 2032, reflecting a robust CAGR of 7.6% from 2025 to 2032. This growth is underpinned by accelerating developments in genomics, personalized medicine, and gene-editing technologies.

In 2024, North America dominated the global market with a 51.58% share, driven by strong research infrastructure, technological leadership, and a growing number of collaborations and acquisitions. The United States remains the core contributor, supported by an advanced biotechnology ecosystem and high adoption of CRISPR-Cas9 and related gene-editing tools that require DNA ligases for precise DNA repair.

DNA ligases play a central role in DNA replication, repair, recombination, and cloning. Their use extends across NGS library preparation, gene synthesis, and molecular diagnostics. This widespread applicability has triggered heightened global demand, especially with the increasing focus on synthetic biology, gene therapy, and customized therapeutics.

Market Growth Drivers

The expanding landscape of gene-editing technologies is one of the strongest market catalysts. The rising investment in CRISPR-Cas9 research, coupled with an increasing number of clinical studies involving engineered cells, is accelerating the demand for high-quality DNA ligases. Notably, in 2024, KSQ Therapeutics received FDA clearance for a CRISPR-Cas9 engineered TIL candidate, highlighting the expanding clinical adoption of gene-editing tools.

Furthermore, the growing number of genetic disorders and the rapid shift toward personalized medicine are reinforcing the need for enzyme-based molecular tools. DNA ligases remain indispensable in therapeutic development pipelines, especially in recombinant DNA and cloning-based methodologies.

Market Restraints and Challenges

Despite strong momentum, the market faces constraints such as off-target effects in gene editing, challenges in enzyme delivery systems, and shortages of skilled molecular biologists. Regulatory complexities around advanced genetic engineering technologies also slow product approvals and commercialization cycles. High costs of specialized ligase enzymes pose an additional barrier for smaller research institutions, particularly in emerging economies.

Opportunity Landscape

Strategic collaborations, technology upgrades, and regional market expansion represent significant growth opportunities. Companies are investing heavily in developing high-efficiency ligases suitable for advanced genomic applications. Examples include acquisitions in the biotechnology sector to expand recombinant enzyme production capabilities, such as Fortis Life Sciences acquiring Empirical Bioscience to strengthen its molecular reagents portfolio.

The Asia Pacific region is emerging as the fastest-growing market due to increasing research capabilities and expanding biopharmaceutical manufacturing facilities. China's investment in commercial DNA fragment production and genomics platforms is boosting regional demand for DNA ligases.

Segmentation Overview

T4 DNA Ligase represented the largest segment in 2024 due to its versatility and wide application in cloning and genetic engineering workflows. Meanwhile, the T7 DNA Ligase segment is forecast to grow rapidly through 2032, driven by applications in synthetic biology and biopharmaceutical research.

In application terms, genomics and genetic engineering dominated the market in 2024, with rising utilization in CRISPR-based editing and customized genome modifications. Pharmaceutical and biotechnology companies accounted for the majority of end-user demand as gene therapy, vaccine development, and recombinant DNA technologies continue to expand.

Regional Outlook Through 2032

  • North America (2024 value: USD 180.9 million) - Leadership driven by strong R&D, high adoption of gene-editing tools, and ongoing mergers.
  • Europe - Second-largest market due to strong academic research and robust regulatory frameworks supporting genomics.
  • Asia Pacific - Expected to register the highest CAGR through 2032 with expanding biotech investments.
  • Latin America & Middle East/Africa - Growth driven by genomics adoption and rising government initiatives.

Key Companies

Major players include Thermo Fisher Scientific, New England Biolabs, Takara Bio, Agilent Technologies, Promega Corporation, Bio-Rad Laboratories, Fortis Life Sciences, and others focusing on enzyme innovation and expanded genomic toolkits.

Segmentation By Type

  • T7 DNA
  • T4 DNA
  • Others

By Application

  • Genomics & Genetic Engineering
  • Drug Discovery & Research
  • Others

By End-user

  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • Others

By Region

  • North America (By Type, Application, End-user, and Country)

U.S.

Canada

  • Europe (By Type, Application, End-user, and Country/Sub-region)

U.K.

Germany

France

Spain

Italy

Scandinavia

Rest of Europe

  • Asia Pacific (By Type, Application, End-user, and Country/Sub-region)

Japan

China

India

Australia

Southeast Asia

Rest of Asia Pacific

  • Latin America (By Type, Application, End-user, and Country/Sub-region)

Brazil

Mexico

Rest of Latin America

  • Middle East & Africa (By Type, Application, End-user, and Country/Sub-region)

GCC

South Africa

    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in DNA Modification Techniques
  • 4.2. Technological Advancements in Genetic Engineering
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnership, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. T7 DNA
    • 5.1.2. T4 DNA
    • 5.1.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Genomics & Genetic Engineering
    • 5.2.2. Drug Discovery & Research
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Pharmaceutical and Biotechnology Companies
    • 5.3.2. Academic & Research Institutes
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. T7 DNA
    • 6.1.2. T4 DNA
    • 6.1.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Genomics & Genetic Engineering
    • 6.2.2. Drug Discovery & Research
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Pharmaceutical and Biotechnology Companies
    • 6.3.2. Academic & Research Institutes
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. T7 DNA
    • 7.1.2. T4 DNA
    • 7.1.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Genomics & Genetic Engineering
    • 7.2.2. Drug Discovery & Research
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Pharmaceutical and Biotechnology Companies
    • 7.3.2. Academic & Research Institutes
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. T7 DNA
    • 8.1.2. T4 DNA
    • 8.1.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Genomics & Genetic Engineering
    • 8.2.2. Drug Discovery & Research
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Pharmaceutical and Biotechnology Companies
    • 8.3.2. Academic & Research Institutes
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. T7 DNA
    • 9.1.2. T4 DNA
    • 9.1.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Genomics & Genetic Engineering
    • 9.2.2. Drug Discovery & Research
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Pharmaceutical and Biotechnology Companies
    • 9.3.2. Academic & Research Institutes
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East and Africa DNA Ligases Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. T7 DNA
    • 10.1.2. T4 DNA
    • 10.1.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Genomics & Genetic Engineering
    • 10.2.2. Drug Discovery & Research
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Pharmaceutical and Biotechnology Companies
    • 10.3.2. Academic & Research Institutes
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights, and Forecast - By Country/Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. New England Biolabs
    • 11.2.3. Danaher Corporation
    • 11.2.4. Fortis Life Sciences, LLC.
    • 11.2.5. Promega Corporation
    • 11.2.6. Bio-Rad Laboratories, Inc.
    • 11.2.7. BioCat GmbH
    • 11.2.8. Takara Bio Inc.
    • 11.2.9. Agilent Technologies, Inc.

List of Tables

  • Table 1: Global DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 2: Global DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 3: Global DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 4: Global DNA Ligases Market Revenue (USD million) Forecast, by Region, 2019-2032
  • Table 5: North America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 6: North America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 7: North America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 8: North America DNA Ligases Market Revenue (USD million) Forecast, By Country, 2019-2032
  • Table 9: Europe DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 10: Europe DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 11: Europe DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 12: Europe DNA Ligases Market Revenue (USD million) Forecast, by Country/Sub-Region, 2019-2032
  • Table 13: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 14: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 15: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 16: Asia Pacific DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2019-2032
  • Table 17: Latin America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 18: Latin America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 19: Latin America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 20: Latin America DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2019-2032
  • Table 21: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Table 22: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Table 23: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Table 24: Middle East & Africa DNA Ligases Market Revenue (USD million) Forecast, By Country/Sub-Region, 2019-2032

List of Figures

  • Figure 1: Global DNA Ligases Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032
  • Figure 2: Global DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 5: Global DNA Ligases Market Value (USD million), by Region, 2024 & 2032
  • Figure 6: North America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 7: North America DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 8: North America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 9: North America DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 10: North America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 11: North America DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 12: North America DNA Ligases Market Value (USD million), By Country, 2024 & 2032
  • Figure 13: North America DNA Ligases Market Value Share (%), By Country, 2024
  • Figure 14: Europe DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 15: Europe DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 16: Europe DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 17: Europe DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 18: Europe DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 19: Europe DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 20: Europe DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 21: Europe DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024
  • Figure 22: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 23: Asia Pacific DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 24: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 25: Asia Pacific DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 27: Asia Pacific DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 29: Asia Pacific DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024
  • Figure 30: Latin America DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 31: Latin America DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 32: Latin America DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 33: Latin America DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 34: Latin America DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 35: Latin America DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 37: Latin America DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024
  • Figure 38: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2024 & 2032
  • Figure 39: Middle East & Africa DNA Ligases Market Value Share (%), by Type, 2024
  • Figure 40: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa DNA Ligases Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2024 & 2032
  • Figure 43: Middle East & Africa DNA Ligases Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa DNA Ligases Market Value (USD million), By Country/Sub-Region, 2024 & 2032
  • Figure 45: Middle East & Africa DNA Ligases Market Value Share (%), By Country/Sub-Region, 2024